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Are immune responses pivotal to cancer
patient’s long term survival?
Two clinical case-study reports on the
effects of Morinda citrifolia (Noni)
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Introduction
Traditionally. physicians prognosticate about cancer
patient sur ival using statistical analysis and compari
son het een roups ot patients at the same stage ot
cancer proression .As our understanding of cancer
biology changes so will our treatment recommenda
tions. Multi-center large scale prospectI’e controlled
clinical trials are needed to demonstrate on an empiri
cal basis, the superiority of new treatments and ne\
approaches to disease management. For solid tumors
in the earl stages. surgery remains the mainstay
standard of care producing a more or less consistent
percentage of apparent cures, Those patients who show
metastases in the postoperative years eventually die
from cancer regardless of additional radiation/cyto
toxic chemotherapy. These modalities taken together
are considered therapeutic failures especially if the
original intent is for cure. For late stage disease (stage
Ill or IV) vs here l mph node metastases are numerous
or distant spread is present at time of surger\ treat
ment intent clearly is palliative. For these cases, new
c totoxic drugs and combinations do not change the
outcome of death due to ravages of cancer but rather.
often at the espense of the quality oflife the very core
altie of living, provide onl modest proloneat ion in
overall stirs ival time measurements.
Recentl. vs ith the advent of anti—aiigioecnesis and
molecular targeted therapies. XCI has holdl\ set a
goal to elnninate sufferiitg and prenaiture death from
cancer h the year 2015. This will turn a conunon fatal
illness to the status ot chronic diseases manageable
like those of diabetes or heart disease. Increasingly.
cancer patients arc looking for answers elsewhere.
mainly in alternative and complementary medicine,
Noni juice from the fruit of Morindacitrifolia has been
shown by Hirazumi and Furasawa,2to have anti-tumor
effects through irnmunomodulatmg mechanisms in
the laboratory. Although testimonials from patients
and theirfamilies abound, no one has demonstrated in
the clinic vs hether Noni juice actually itllproves long
term outcome. Phase I N Il-I funded clinical trial with
standardized Noni extract is still ongoing and results
less than 2 sears are encouraging. according to news
released by principal investigator Dr. Brian Issell of
the 1/H Cancer Research Center.1 Here the author
reports 2 clinical case studies pointing to Noni juice
making a difference in terms of disease control over
many years.
Methodology
Medical records from clinics, hospitals and hospice
nurses were reviewed in detail. In Case I, X-ray and
imaging studies v crc also reviewed with a radiologist
and biopsy slides vs ith pathologists. Apparent excel
lent health and multiple in-depth interviews with
patient and relatives led to a clinical evaluation and
a follow-up endoscopy with biopsy, 6 years: after
onset of symptoms. and diaenosis by the original
gastroenterologist. In case 2. the study was limited
to review of complete medical records from hospital
andclinic. death certificate, telephone inters iess s vs ith
his surviving son and person vs ho prepared Noni juice
for the patient.
Case Study Reports
Case I
MCI (WCI fkIlicnt //c,ztitkvttio, (Ode 1100/C fo,
pmuuIioIl 1/ /0/lOt vi. at age 69 developed progres
sive anore sia. epigastric discomfort and vs eight
loss, At endoscop\ a ps lone channel ulcer vs as seen
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and biopsy revealed poorly differentiated invasive
adenocarcinoma. diffuse type v ith sienet ring cells.
He refused suruerv after consulting a surgeon. He
left the hospital not accept inc sound advice from
castroenterologist. family ph sician and surgeon. He
deteriorated o er 2 months. becoming bedridden. His
veight dropped from I 05 lbs to “k) lbs and he could
barely retain liquids orally v ith intermittent vomiting.
A hospice nurse was engaged to care for him, expect
ing him to die in a short time, On his death bed MCI
decided to take homemade Noni juice. Remarkably
he improved rapidly and within a month was able to
ingest a regular diet and started to regain his weight.
Soon he v as able to resume his act ivitv as a hunter
and fisherman. He refused to see any regular doctor
after that episode. Seven ‘ears later MCI does not
have an’ gastric s\ mptoms. lie had stopped taking his
\oni juice rcgu lark after the first 0 months. Prior t
discharge from hospice care at one year after admis
sion, his [‘Cii X—ray examination sv as normal. On Feb
2003 almost 6 ears alter diagnosis. MCi under
svent his first follow—up endoscop which revealed an
atypical prepvloric ulcer. Biopsy at this time showed
histology similar to his initial biopsy of cancer. To
date. MCi still persists in his decision not to consider
surgical therapy but to continue self-treatment with
homemade Noni juice.
Case 2
MC2 rMC2— porte/il ide,il,/ieunon code lUll/ic’ tot’
prolecholl of prti’acv). onset at age 64 developed
progressiv e eating diffcult and weight loss. At
esophagogastroscopv a constricting malignant look
ing lesion was found at the esophagogastric Junction.
Biopsy showed adenocarcinoma. At surgery, no gross
liver metastasis was noted. A proximal gastrectom
with en bloc removal of the spleen and tail of pancreas
was performed. because of firm adhesion of the rather
large neoplastic tissue which had perforated through
the stomach wall posteriorly to these structures. Frozen
section of the esophagus resection margin showed
residual cancer and the anastomosis was redone.
The margin fro,en section was cleared this 2° time.
No adjuv ant chemotherap therapy as available or
recommended. Pathologist reported cancer infiltra
tion through the gastric serosa ithout invasion of
the spleen. pancreas or oinentunt . Metastatic carci
noma was Ibund in 17 of 28 lymph nodes examined.
Histolog of the cancer was poorl differentiated
adenocarcinoma. ulcerated, with marked lymphocvtic
and plasma cell infiltration,
1v1C2 develcped a benign stricture at the esophago
gastric anastomosis and several biopsies were done at
the time of subsequentdilations which were repeatedly
requit-ed several times per year. In the ensuing 16 years
his doctors could not find evidence of recurrence.
Eventuall\ at age 80 he refused to undergo any more
1//inti’ation,s s/ion se/cried i/sieges f,sen i’udnwrip/uc amd il!iUgilig snidie.s of liIC1
dilation procedures and he died. The cause of death listed in the death certificate
was malnutrition due to benign stricture and history of gastric cancer. His son
claims that the good outcome is attributable to patient’s use of homemade Noni
juice. In retrospect. surgery here must he considered curative despite the late stage
of discovery. Ordinarily, surgeons would treat this as a palliative attempt, with 5
\ ear survival statistics in the single digits Sixteen—year disease fi’ee survival is
unheard of.
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Discussion
In case I patient had a remarkable reversal of his symptoms ithout surgcr or
other conventional therapies. Because of this tact. MCI presents a unique op
portunitv for a study on immunity and cancer. The uniqueness is that researchers
can completely separate the effects of immune responses together with genetic
factors from those of standard therapy. If patient had surgery and/or other con
ventional therapies the case would render any study of this relationship difficult
if not impossible. Four physicians had told patient that without surgery he would
die within a few months. He took unknown risks at his peril and survived. He
unwittingly became both experimenter and the subject of experimentation. Under
these circumstances no rational person would choose not to have surgery in this
present da\ and age. This index case casts doubt on our abilit to prognosticate
untreated gastric cancer using statistics based on pre-surger era. Physicians may
be tempted to simply assign causes for the prolonged sYmptom-free remission
to one of luck or unknown factors though. clearly, patient’s turnaround followed
soon after the outset of consuming homemade Noni Juice. Instead, there is a le
gitimate question: did the immunomodulation properties of Noni juice contribute
significantly to patient’s outcome?
In case 2, it is more dubious. hut given the pathological findings ofT3N3 (stage
IV) disease, the same question remains in the minds of the author.
In March 2003. MacKie and Reid4 from United Kingdom reported a fatal
metastatic melanoma in the recipient of a transplanted kidne\ from a cada er
donor who had a history of surgical removal of a melanoma 16 years prior to
donation and ithout evidence of recurrence at the time of death. Doctors worked
hard and were able to prevent another fatal outcome on the 2nd recipient of the
contra—lateral kidney v hich also developed metastatic melanoma. The authors
recommended thathistory of melanomaremo al, even without evmdenceofdtsease
after many yeari.. represents an absolute contraindication to organ donation since
immunosuppression will unravel metastatic disease in the recipients. Today the
medical community is more inclined to accept immune responses to be the major
mechanism responsible for spontaneous regression or long lasting natural control
of occult metastases. Here the contention is that case 2 represents an instance of
micrometastases being kept in check by the immune system. Perhaps students
of medical science can speculate b extrapolation a similar scenario in other iii-
stances of apparent surgical cures. Along this line of
reasoning it will inevitab1 lead us to surmise at the
validity of Immunologic Surveillance of Neoplasia
theory proposed b F \I Burnett. Gi en the dismal
prognosis of advanced stage cancers treated with the
newest evidence-based therapeutic regimen. new ap
proaches such as adjuvant immunotherap are much
needed. In I Ja au .Noni is en joy ing great popularity
and is abundantly available. It is the author’s hypothesis
that immune responses, whether naturall\ occurrinLe
from favorable genetic factors alone andior a result
of the sum of genetic factors plus those induced by
immunostimulants. do play a pivotal role in cancer
patients’ sur\ ival. Dr Zheng Cui of the Wake Forest
Uniyersitv School of Medicine recentl described the
discovery of CRSR strain of mice. v hich exhibits
remarkable spontaneous rejection of’ Sarcoma I 8C.-
To the authors delight, DrZ. Cui and his collaborators
have accepted the grave amid serious responsibility to
perform on this surviving patient MCI, immunologi
cal and genetic studies analogous to those done on his
remarkable mice. From these studies, a new aspect
of the knowledge of cancer biology in the laboratory
mice and humans may possibly be found.
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